A Dutch life-science firm plans to launch its first U.S. lab at Keene State College in two weeks, and it envisions the Elm City as a base to cultivate biotech research in the region.
Detact Diagnostics, which focuses on preventing bacterial contamination in medical settings, is scheduled to activate its lab Dec. 15 after finalizing an agreement with Keene State on Nov. 2, according to representatives of both parties. The firm announced plans in May to establish its U.S. headquarters in Keene while working with Hannah Grimes’ BioNest Program.
Detact CEO Dr. Joost Gazendam said he founded the company based on his work as a trauma surgeon out of a need to distinguish inflammation, the natural reaction of the body’s immune system to an irritant, and infection, which involves the presence of bacteria.